April 18, 2020 • 1:00 PM – 5:00 PM
Medication Assisted Treatment (MAT) Training for
Opioid Addiction Waiver In-Person
'Half and Half' training, i.e. half online & half in-person
*Developed for the American Academy for Addiction Psychiatry
This course is suitable for providers who would like to obtain a waiver for their DEA license to prescribe buprenorphine products for opiate use disorder. The course is offered with a compulsory online component and 4 hours in person training.
DATA Sponsor: AAAP is the DATA 2000 Sponsor for this training
- Screen and identify patients with Opioid Use Disorder (OUD) and define evidence-based treatments.
- Discuss the pharmacology of opioids as it relates to treatment of OUD patients.
- Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
- Explain the process of buprenorphine induction as well as stabilization and maintenance.
- Discuss all FDA approved antagonist and agonist medications to treat OUD.
- Discuss basic office protocols including medical record documentation and confidentially.
- Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
- Recognize the importance of obtaining a waiver to begin treating patients with OUD.
Modules Covered in the Course:
Jeff Watts, MD
Psychiatrist and Addiction Medicine Physician
Cook County Health and Hospitals System
Following completion of the in person training, the AACP will send a link to the online training half. There will be three modules to review followed by a 20 question exam. Once the exam is passed, a Certificate of Completion will be provide with instructions on applying for the waiver. On line training must be completed within 30 days of receiving the link.
NPs/PAs can take the 8 hour waiver training and it will count towards their waiver application. The additional 16 hours of training is available on PCSS at no cost: https://pcssnow.org/education-training/mat-training/
Residents can take the waiver training; they will not be able to apply until they have a personal DEA number and an unrestricted medical license.
This activity has been approved for AMA PRA Category 1 Credit™
This activity will be certified for ANCC contact hours (including pharmacotherapeutic contact hours)
and will award AAPA Category 1 CME credit.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.